Charles Hurty - IShares MSCI Independent Director
| EEM Etf | USD 43.27 0.09 0.21% |
Mr. Charles A. Hurty is Independent Director of iShares MSCI Emerging Markets. He was a Trustee of the Trust since 2005 and Chairman of the Audit Committee of the Trust since 2006. Mr. Hurty has served as a Director of iShares, Inc. since 2005, Chairman of the Audit Committee of iShares, Inc. since 2006, a Director of iShares MSCI Russia Capped Index Fund, Inc. since 2010 and Chairman of the Audit Committee of iShares MSCI Russia Capped Index Fund, Inc. since 2010. In addition, Mr. Hurty serves as Director of the GMAM Absolute Return Strategy Fund since 2002, Director of the SkyBridge MultiAdviser Hedge Fund Portfolios LLC since 2002 and was a Director of the CSFB Alternative Investment Funds from 2005 to December 2009, when the funds were liquidated. Mr. Hurty was formerly a Partner at KPMG, LLP from 1968 to 2001
| Age | 72 |
| Tenure | 19 years |
| Web | http://www.ishares.com/us/products/239637/ishares-msci-emerging-markets-etf |
| Issuer | iShares |
| Inception Date | 2003-04-07 |
| Benchmark | MSCI Emerging Markets Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 17.66 Billion |
| Average Trading Valume | 25.42 Million |
| Asset Type | Equity |
| Category | Broad Equity |
| Focus | Strategy |
| Market Concentration | Emerging Markets |
Similar Fund Executives
| Found 12 records | One Year Return | ||
| Robert Silver | iShares MSCI Brazil | 57 | |
| John Martinez | iShares MSCI Japan | 55 | |
| Cecilia Herbert | iShares MSCI Japan | 67 | |
| Robert Kapito | iShares MSCI Brazil | 61 | |
| John Kerrigan | iShares MSCI Japan | 60 | |
| George Parker | iShares MSCI Japan | 79 | |
| John Martinez | iShares MSCI Brazil | 55 | |
| John Kerrigan | iShares MSCI Brazil | 60 | |
| Madhav Rajan | iShares MSCI Japan | 52 | |
| Cecilia Herbert | iShares MSCI Brazil | 67 | |
| Madhav Rajan | iShares MSCI Brazil | 52 | |
| Robert Kapito | iShares MSCI Japan | 61 | |
iShares MSCI Emerging Money Managers
| Robert Silver, Independent Chairman of the Board | ||
| John Kerrigan, Independent Director | ||
| Madhav Rajan, Independent Director | ||
| Cecilia Herbert, Independent Director | ||
| Michael Latham, President Director | ||
| Jack Gee, Chief Financial Officer, Treasurer | ||
| Charles Hurty, Independent Director | ||
| Edward Baer, Chief Legal Officer, Vice President | ||
| Eilleen Clavere, Secretary | ||
| Scott Radell, Executive Vice President | ||
| George Parker, Independent Director | ||
| John Martinez, Independent Director | ||
| Amy Schioldager, Executive Vice President | ||
| Robert Kapito, Director | ||
| Ira Shapiro, Vice President |
IShares Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IShares MSCI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Operating Margin | 68.07 % | |||
| Current Valuation | 28.15 B | |||
| Shares Outstanding | 752.4 M | |||
| Shares Owned By Insiders | 0.29 % | |||
| Shares Owned By Institutions | 77.52 % | |||
| Price To Earning | 2.98 X | |||
| Price To Book | 1.37 X | |||
| Price To Sales | 68.86 X | |||
| Revenue | 532.42 M | |||
| Gross Profit | 341.73 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in iShares MSCI Emerging. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
The market value of iShares MSCI Emerging is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares MSCI's value that differs from its market value or its book value, called intrinsic value, which is IShares MSCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares MSCI's market value can be influenced by many factors that don't directly affect IShares MSCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares MSCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares MSCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares MSCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.